Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma.
Saved in:
| Title: | Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced Melanoma. |
|---|---|
| Authors: | Martínez-Vila, Clara1,2 (AUTHOR), Teixido, Cristina2,3,4,5 (AUTHOR), Martín, Roberto1,3,5,6 (AUTHOR), Aya, Francisco1,4,5,6 (AUTHOR), Sudhaman, Sumedha5,7 (AUTHOR), Budde, Griffin L.6,7 (AUTHOR), González-Navarro, Europa Azucena6,7,8 (AUTHOR), Alos, Llucia4,6,8 (AUTHOR), Castrejon, Natalia1,4,6 (AUTHOR), Ortiz, J. Bryce2,7 (AUTHOR), Krainock, Michael3,7 (AUTHOR), Liu, Minetta C.4,7 (AUTHOR), Arance, Ana1,5,6 (AUTHOR) amarance@clinic.cat |
| Source: | Cancers. Dec2025, Vol. 17 Issue 23, p3804. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers17233804 |
